Follow
Constanze Mittermeier
Constanze Mittermeier
LMU Munich, Walther Straub Institute of Pharmacology and Toxicology
Verified email at lrz.uni-muenchen.de
Title
Cited by
Cited by
Year
TRPM7 kinase activity is essential for T cell colonization and alloreactivity in the gut
A Romagnani, V Vettore, T Rezzonico-Jost, S Hampe, E Rottoli, ...
Nature communications 8 (1), 1917, 2017
922017
Filamin A interacts with the coactivator MKL1 to promote the activity of the transcription factor SRF and cell migration
P Kircher, C Hermanns, M Nossek, MK Drexler, R Grosse, M Fischer, ...
Science signaling 8 (402), ra112-ra112, 2015
672015
Inhibition of TRPM7 blocks MRTF/SRF-dependent transcriptional and tumorigenic activity
S Voringer, L Schreyer, W Nadolni, MA Meier, K Woerther, C Mittermeier, ...
Oncogene 39 (11), 2328-2344, 2020
482020
The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma
C Hermanns, V Hampl, K Holzer, A Aigner, J Penkava, N Frank, DE Martin, ...
Oncogene 36 (24), 3464-3476, 2017
422017
Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
C Mittermeier, A Konopa, S Muehlich
Cells 9 (12), 2540, 2020
292020
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Controls HCC Growth and Senescence
L Schreyer, C Mittermeier, MJ Franz, MA Meier, DE Martin, KC Maier, ...
Cancers 13 (21), 5373, 2021
152021
Unravelling a new mechanism linking actin polymerization and gene transcription
S Muehlich, C Hermanns, MA Meier, P Kircher, T Gudermann
Nucleus 7 (2), 121-125, 2016
152016
The transmembrane protein tetraspanin 5 controls the effects of loss of the tumor suppressor deleted in liver cancer 1 (DLC1) on hepatocellular carcinoma (HCC) growth
L Schreyer, C Mittermeier, DE Martin, S Singer, B Liebl, T Gudermann, ...
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 394 (SUPPL 1), S14-S14, 2021
2021
Formation of the novel MKL1-Filamin A complex upon loss of the tumor suppressor deleted in liver cancer 1 (DLC1) promotes hepatocellular carcinoma growth
MA Meier, K Woerther, C Hermanns, T Gudermann, S Muehlich
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 391, S57-S58, 2018
2018
The novel MKL1/2 dependent target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma
CGM Mittermeier
lmu, 2017
2017
The novel MKL target gene MYOF (myoferlin) modulates expansion and senescence of hepatocellular carcinoma
C Hermanns, V Hampl, A Aigner, S Singer, A Thavamani, A Nordheim, ...
Naunyn-Schmiedebergs Archives of Pharmacology, S7-S7, 2016
2016
Expression profiling of novel MKL target genes involved in HCC growth identifies Myoferlin as the mediator of the MKL-associated senescence response
C Hermanns, V Hampl, A Aigner, D Martin, K Maier, T Gudermann, ...
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 388, S76-S76, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–12